ClinicalTrials.gg
RecruitingNCT06504277Updated Jul 31, 2025

Low Versus Standard Pressure Pneumoperitoneum on Shoulder Tip Pain

An interventional study of Low Pressure Penumoperitoneum and Standard Pressure Group (No intervention- active comparator) in Surgery, Laparoscopic and Laparoscopy, sponsored by Mount Sinai Hospital, Canada. Recruiting at 1 site in Canada. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-31.

Sponsored by Mount Sinai Hospital, Canada · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Jul 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 190 studies in Pain, Postoperative with a site in Canada — 38 open to participants now, 42 under way, 3 of them phase 3. Pain, Postoperative · Canada.

Planned enrollment
88th of 175
82 · median 82
Started
2025
with 11 others
No phase
94 of 190
17 open now
Primary completion
2026-07
later than 19 of 41 live
Registered
176th of 190
by date

Among the 190 studies in Pain, Postoperative with a site in Canada, this one is the 88th largest by planned enrollment of the 175 interventional ones that give a count, is one of 12 that started in 2025, is one of 94 with no phase, reaches primary completion later than 19 of the 41 other live ones, and was the 176th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

38 of the 190 studies in Pain, Postoperative with a site in Canada are open now. Recruiting first, the newest first:

32 more — sign in →

All 38 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 190 studies in Pain, Postoperative with a site in Canada, or all of them as a file.
02

Study summary

This proposed study is a single-center, double blind, parallel group RCT comparing the use of low (10 mm Hg) versus standard pressure (15 mm Hg) pneumoperitoneum at the time of benign gynecologic laparoscopic surgery. Patients will be randomized to the control group (standard pressure) or the intervention group (low pressure) and surgeons will be blinded to the study pressure. Data on post-operative recovery and pain scores will be recorded for each patient.

Read the detailed description

Primary Objective: The primary objective of this study is to determine the effect of low (10 mm Hg) versus standard pressure (15 mm Hg) pneumoperitoneum on post-operative shoulder pain on post operative day one following laparoscopic gynecologic surgery for benign indication.

Secondary Objective: Secondary outcomes measured will include post-operative shoulder tip pain at 1 and 2 hours, QoR score (Appendix A) on POD 1, incidence of post-operative shoulder tip pain (defined as pain rating above zero) at 1, 2, and POD 1, generalized pain, nausea and bloating at 1 and 2 hours and POD 1, as well as rescue analgesia consumption before discharge and use up to POD1. The investigators will also measure intraoperative time, complication rates, estimated blood loss, surgeon visibility rating and anesthetist satisfaction rating, and time to patient discharge. Additionally, investigators will assess rate of failure to complete the surgery at designated pressure (i.e. request to increase pressure).

This proposed study is a single-center parallel group RCT comparing the use of low (10 mm Hg) versus standard pressure (15 mm Hg) pneumoperitoneum at the time of benign gynecologic laparoscopic surgery. Participants will be selected using a convenience sample from Women's College Hospital operating room list. All potentially eligible patients will be invited to participate in this study by the MIS fellow on the day of surgery up to 2 hours before the scheduled surgery. Study consent will be obtained by the MIS fellow or research assistant after the patient has had sufficient time to consider participation in the study.

The investigators will create a randomization list using a computer-generated allocation sequence in equal ratio with study numbers 1 to 82. A member of the research team who will have no interaction with patients in this study will prepare the low and standard pressure envelopes and label them according to the randomization list. Study participants will be randomized on the day of surgery, and the research nurse will set the insufflation pressure to the pre-randomized pressure identified in the envelope. The surgeon, research team, participants and data analysts will be blinded to treatment group. Patients will receive standardized peri-operative care during their operation.

Post-operative pain, nausea, and medication use will be assessed in the PACU. Patients will also be contacted on POD1 to assess post-operative pain scores, calculate total narcotic consumption and elicit any adverse events.

Primary Endpoints: The primary endpoint is post-operative shoulder tip pain measured on POD 1 following surgery by a self-administered NRS for pain. A NRS is a line measuring from 0-10 that rates pain from none (0) to the worst pain imaginable (10). A NRS for subjective pain assessment is a well-established validated measurement tool that has been shown in numerous studies to provide a clinically useful distribution of responses and a detectable treatment effect [Clivatti et al, 2009].

Secondary Endpoints: Secondary outcome measures will include: (a) NRS scores for shoulder-tip pain at 1 and 2 hours (b) QoR score on POD1, (c) NRS scores for generalized pain at 1 and 2 hours and on POD1 (d) post operative nausea, vomiting, and bloating at 1 and 2 hours and on POD1 (e) narcotic consumption measured as total dose of narcotics in PACU and between discharge and the POD1 phone call (f) surgical time (g) estimated blood loss (h) adverse effects/complication rates in hospital and reported by the POD1 phone call (i) surgeon visibility rating and (j) anesthetist satisfaction rating.

03

Conditions studied

  • Surgery
  • Laparoscopic
  • Laparoscopy
  • Penumoperitoneum
  • Post-operative Pain
  • Post-operative Recovery

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: The participant must meet all of the inclusion criteria to eligible for this clinical trial:

  1. All ages > or = to 18 years old;
  2. Must be deemed to have capacity to provide ;
  3. Must sign and date the informed consent form;
  4. Stated willingness to comply with all study procedures;
  5. Must be undergoing unilateral or bilateral salpingo-oopherectomy or salpingectomy or ovarian cystectomy;

Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in this clinical trial:

  1. Previous midline laparotomy;
  2. Gynecological cancer beyond stage 1 disease;
  3. Chronic pain;
  4. Known diagnosis of endometriosis or evidence of endometriosis intra-operatively;
  5. Fibromyalgia;
  6. >50;
  7. Language barrier;
  8. Inability to communicate or provide informed consent;
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
82 participants (estimated)

Study arms

  • Active comparator
    Standard Pressure

    Patients undergoing laparosocpy at standard pressure (15 mm Hg)

    Other: Standard Pressure Group (No intervention- active comparator)

  • Experimental
    Low Pressure

    Patients undergoing experimental intervention of low pressure pneumoperitoneum (10 mm Hg)

    Procedure: Low Pressure Penumoperitoneum

Interventions

  • ProcedureLow Pressure Penumoperitoneum

    Maintained Pneumoperitoneum with low pressure of 10 mm Hg

  • OtherStandard Pressure Group (No intervention- active comparator)

    Maintained Pneumoperitoneum at standard pressure of 15 mm Hg

06

What researchers measure

Primary outcomes

  1. Shoulder Tip Pain

    The primary endpoint is post-operative shoulder tip pain measured on post-op day 1 following surgery by a self-administered NRS (numeric rating score) for pain, on a scale from 0 (no pain) to 10 (worst pain imaginable).

    Time frame: Post-op day 1

Secondary outcomes

  1. Shoulder Tip Pain (Short-term)

    NRS (numeric rating score) scores for shoulder-tip pain at 1 and 2 hours on a scale from 0 (no pain) to 10 (worst pain imaginable)

    Time frame: 1 and 2 hours after surgery

  2. Quality of Recovery (QoR) score

    QoR (Quality of Recovery) score on post-op day 1: a pre-validated score out of 150 (higher score corresponds to better recovery)

    Time frame: Post-op day 1

  3. Generalized Pain Score

    Generalized pain at 1 and 2 hours and on post-op day 1. Self-reported NRS pain score on a scale 0-10.

    Time frame: 1, 2 hours post-op and post-op day 1

  4. Incidence of Nausea and Vomitting

    Documented incidence (yes or no) of nausea, vomiting, and bloating at 1 and 2 hours and on post-op day 1. Incidence/presence of nausea and vomiting is worse.

    Time frame: 1, 2 hours post-op and post-op day 1

  5. Narcotic use

    Narcotic consumption measured as total dose of narcotics in PACU and between discharge and the post-op day1 phone call

    Time frame: Post-op day 1

  6. Surgical time

    Duration of surgery

    Time frame: Duration of surgery (day surgery)

  7. Estimated blood loss

    Estimated blood loss

    Time frame: Duration of surgery (day surgery)

  8. Adverse Effect/Complications

    Adverse effects/complication rates in hospital and reported by post-op day 1 phone call

    Time frame: Post-op day 1

  9. Surgeon visibility

    Surgeon visibility rating: visibility during surgery assessed by surgeon rating on a 5-point Likert scale. Greater score indicates better visibility.

    Time frame: Duration of surgery

  10. Anesthetist satisfaction

    Anesthetist satisfaction rating measured as anesthetist satisfaction with ventilation during surgery. Assessed by anesthetist rating on a 5-point Likert scale (higher score is better).

    Time frame: Duration of surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Jul 2026, 12 months after the start.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 12 months is close to that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 4, 2024
First posted
Jul 16, 2024
StartActual
Jul 2, 2025
Primary completionEst.
Jul 10, 2026
CompletionEst.
Sep 15, 2026
Last update
Jul 31, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06504277
Collaborators
Women's College Hospital
Responsible party
Mara Sobel (Associate Professor, Mount Sinai Hospital, Canada) — Principal investigator
First posted
Jul 16, 2024
Start date
Jul 2, 2025
Primary completion
Jul 10, 2026 (estimated)
Completion
Sep 15, 2026 (estimated)
Last update
Jul 31, 2025

Study contacts

Sara Hojabri, MBBCHBAO
Contact
sara.hojabri@mail.utoronto.ca
6474047614
Mara Sobel, MD, MSC
Contact
mara.sobel@sinaihealth.ca
9055155186

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion